Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey

Abstract

Purpose

Rural cancer survivors may disproportionately experience financial problems due to their cancer because of greater travel costs, higher uninsured/underinsured rates, and other factors compared to their urban counterparts. Our objective was to examine rural-urban differences in reported financial problems due to cancer using a nationally representative survey.

Methods

We used data from three iterations of the National Cancer Institute’s Health Information and National Trends Survey (2012, 2014, and 2017) to identify participants who had a previous or current cancer diagnosis. Our outcome of interest was self-reported financial problems associated with cancer diagnosis and treatment. Rural-urban status was defined using 2003 Rural-Urban Continuum Codes. We calculated weighted percentages and Wald chi-square statistics to assess rural-urban differences in demographic and cancer characteristics. In multivariable logistic regression models, we examined the association between rural-urban status and other factors and financial problems, reporting the corresponding adjusted predicted probabilities.

Findings

Our sample included 1359 cancer survivors. Rural cancer survivors were more likely to be married, retired, and live in the Midwest or South. Over half (50.5%) of rural cancer survivors reported financial problems due to cancer compared to 38.8% of urban survivors (p = 0.02). This difference was attenuated in multivariable models, 49.3 and 38.7% in rural and urban survivors, respectively (p = 0.06).

Conclusions

A higher proportion of rural survivors reported financial problems associated with their cancer diagnosis and treatment compared to urban survivors. Future research should aim to elucidate these disparities and interventions should be tested to address the cancer-related financial problems experienced by rural survivors.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289. https://doi.org/10.3322/caac.21349

    Article  PubMed  Google Scholar 

  2. 2.

    Yabroff KR, Lund J, Kepka D, Mariotto A (2011) Economic burden of cancer in the US: estimates, projections, and future research. Cancer Epidemiol Biomark Prev 20(10):2006–2014. https://doi.org/10.1158/1055-9965.EPI-11-0650

    Article  Google Scholar 

  3. 3.

    Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710–3717. https://doi.org/10.1002/cncr.28262

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 34(3):259–267. https://doi.org/10.1200/jco.2015.62.0468

    Article  PubMed  Google Scholar 

  5. 5.

    Yabroff KR, Zhao J, Zheng Z, Rai A, Han X (2018) Medical financial hardship among cancer survivors in the United States: what do we know? What do we need to know? Cancer Epidemiol Biomark Prev 27:1389–1397

    Article  Google Scholar 

  6. 6.

    Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Haynes KE (2018) Financial impact of breast cancer in black versus white women. J Clin Oncol (36(17)):1695–1701. https://doi.org/10.1200/JCO.2017.77.6310

  7. 7.

    Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE (2013) Impact of rural residence on forgoing healthcare after cancer because of cost. Cancer Epidemiol Biomark Prev 22(10):1668–1676. https://doi.org/10.1158/1055-9965.epi-13-0421

    Article  Google Scholar 

  8. 8.

    Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P (2015) Challenges of rural cancer care in the United States. Oncology (Williston Park) 29(9):633–640

    Google Scholar 

  9. 9.

    McDougall JA, Banegas MP, Wiggins CL, Chiu VK, Rajput A, Kinney AY (2018) Rural disparities in treatment-related financial hardship and adherence to surveillance colonoscopy in diverse colorectal cancer survivors. Cancer Epidemiol Biomark Prev 27(11):1275–1282. https://doi.org/10.1158/1055-9965.epi-17-1083

    Article  Google Scholar 

  10. 10.

    Mathews M, West R, Buehler S (2009) How important are out-of-pocket costs to rural patients’ cancer care decisions? Can J Rural Med 14(2):54–60

    PubMed  Google Scholar 

  11. 11.

    Whitney RL, Bell JF, Reed SC, Lash R, Bold RJ, Kim KK et al (2016) Predictors of financial difficulties and work modifications among cancer survivors in the United States. J Cancer Surviv 10(2):241–250

    Article  Google Scholar 

  12. 12.

    WeStat (2017) Health Information National Trends Survey 5 (HINTS 5) Cycle 1 Methodology Report July 2017. https://hints.cancer.gov/docs/methodologyreports/HINTS5_Cycle_1_Methodology_Rpt.pdf Accessed 1 October 2018

  13. 13.

    National Cancer Institute (2018) HINTS Public Use Dataset. Available at https://hints.cancer.gov/data/download-data.aspx Accessed on 1 August 2018

  14. 14.

    Czajka JL and Beyler A. Declining response rates in federal surveys: trends and implications. https://aspe.hhs.gov/system/files/pdf/255531/Decliningresponserates.pdf. Accessed 23 Sept 2018

  15. 15.

    United States Department of Agriculture (2016). Rural Urban Continuum Codes. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes. Accessed 1 Aug 2018

  16. 16.

    Greenberg AJ, Haney D, Blake KD, Moser RP, Hesse BW (2018) Differences in access to and use of electronic personal health information between rural and urban residents in the United States. J Rural Health 34 Suppl 1:s30-s8 doi 10.1111/jrh.12228:s30–s38

    Article  Google Scholar 

  17. 17.

    National Cancer Institute (2017) Analytics recommendations for HINTS 5, Cycle 1 Data November, 2017. https://hints.cancer.gov/data/download-data.aspx Accessed 1 October 2018

  18. 18.

    van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16(3):219–242. https://doi.org/10.1177/0962280206074463

    Article  PubMed  Google Scholar 

  19. 19.

    Lee KJ, Carlin JB (2012) Recovery of information from multiple imputation: a simulation study. Emerg Themes Epidemiol 13(9(1)):3. https://doi.org/10.1186/1742-7622-9-3

    Article  Google Scholar 

  20. 20.

    Graubard BI, Korn EL (1999) Predictive margins with survey data. Biometrics 55(2):652–659

    CAS  Article  Google Scholar 

  21. 21.

    SAS Institute Inc. (2009) SAS/STAT ® 9.2 User’s Guide SEC. SAS Institute Inc, NC, p 2018

    Google Scholar 

  22. 22.

    Probst JC, Moore CG, Glover SH, Samuels ME (2004) Person and place: the compounding effects of race/ethnicity and rurality on health. Am J Public Health 94(10):1695–1703

    Article  Google Scholar 

  23. 23.

    Jagsi R, Ward KC, Abrahamse PH, Wallner LP, Kurian AW, Hamilton AS et al (2018) Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer. Cancer 124(18):3668–3676. https://doi.org/10.1002/cncr.31532

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Shih YT, Chien CR (2017) A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer 123(6):928–939. https://doi.org/10.1002/cncr.30423

    Article  PubMed  Google Scholar 

  25. 25.

    Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D et al (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874. https://doi.org/10.1200/JCO.2009.23.1183

    Article  PubMed  Google Scholar 

  26. 26.

    Shankaran V, Leahy T, Steelquist J, Watabayashi K, Linden H, Ramsey S et al (2018) Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 14:e122–e129

    Article  Google Scholar 

  27. 27.

    Zullig LL, Wolf S, Vlastelica L, Shankaran V, Zafar SY (2017) The role of patient financial assistance programs in reducing costs for cancer patients. J Manag Care Spec Pharm 23:407–411

    PubMed  Google Scholar 

  28. 28.

    Zafar SY, Chino F, Ubel PA, Rushing C, Samsa G, Altomare I et al (2015) The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care 21(9):607–615

    PubMed  Google Scholar 

  29. 29.

    Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22. https://doi.org/10.1007/s00520-011-1270-1

    Article  PubMed  Google Scholar 

  30. 30.

    Vanderpool RC, Nichols H, Hoffler EF, Swanberg JE (2017) Cancer and employment issues: perspectives from cancer patient navigators. J Cancer Educ 32(3):460–466. https://doi.org/10.1007/s13187-015-0956-3

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Palomino H, Peacher D, Ko E, Woodruff SI, Watson M (2017) Barriers and challenges of cancer patients and their experience with patient navigators in the rural US/Mexico border region. J Cancer Educ 32(1):112–118. https://doi.org/10.1007/s13187-015-0906-0

    Article  PubMed  Google Scholar 

  32. 32.

    Inrig SJ, Higashi RT, Tiro JA, Argenbright KE, Lee SJ (2017) Assessing local capacity to expand rural breast cancer screening and patient navigation: an iterative mixed-method tool. Eval Program Plann 61:113–124. https://doi.org/10.1016/j.evalprogplan.2016.11.006

    Article  PubMed  Google Scholar 

  33. 33.

    Gordon LG, Merollini KMD, Lowe A, Chan RJ (2017) A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient 10(3):295–309. https://doi.org/10.1007/s40271-016-0204-x

    Article  PubMed  Google Scholar 

  34. 34.

    Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103(2):117–128. https://doi.org/10.1093/jnci/djq495

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Shih YT, Smielauskas F, Geynisman DM, Kelly RJ, Smith TJ (2015) Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol 33(19):2190–2196

    Article  Google Scholar 

  36. 36.

    Tran G, Zafar SY (2018) Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med 6(9):166

    Article  Google Scholar 

  37. 37.

    Srinivasan S, Moser RP, Willis G, Riley W, Alexander M, Berrigan D et al (2015) Small is essential: importance of subpopulation research in cancer control. Am J Public Health 105(Suppl 3):S371–S373. https://doi.org/10.2105/ajph.2014.302267

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Data

This study used secondary data from the National Cancer Institute. The “Data Terms of Use” does not allow for release of data by data users. However, these data are publicly available from the National Cancer Institute and available for download on their website upon acknowledgement of the “Data Terms of Use.”

Funding

This publication was supported, in part, by the Cancer Prevention and Control Research Network, funded by the Centers for Disease Control and Prevention and the National Cancer Institute (3 U48 DP005000-01S2, University of South Carolina PI: Friedman, Authors: Zahnd, Odahowski, and Eberth; 3 U48 DP005006-01S3, Oregon Health & Science University PI: Shannon and Winters-Stone, Authors: Davis, Perry, Farris, Shannon; 3 U48 DP005014-01S2, University of Kentucky PI: Vanderpool, Author: Vanderpool; 3 U48 DP005013-01S1A3, University of Washington PI: Hannon, Author: Ko; and 3 U48 DP005017-01S8, University of North Carolina PI: Wheeler, Authors: Wheeler and Rotter). Melinda Davis was supported in part by an NCI K07 award (1K07CA211971-01A1). Linda Ko was supported in part by a grant from the Clinical and Translational Science Awards program (UL1 TR002319). This study was also supported by the Federal Office of Rural Health Policy (FORHP), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS) under cooperative agreement [5 U1CRH30539-03-00; Eberth, Zahnd, Odahowski].

Author information

Affiliations

Authors

Corresponding author

Correspondence to Whitney E. Zahnd.

Ethics declarations

Conflicts of interest

The authors declare they have no conflicts of interest.

Disclaimer

The information, conclusions, and opinions expressed in this brief are those of the authors and no endorsement by FORHP, HRSA, CDC, NIH, or HHS is intended or should be inferred.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 19 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zahnd, W.E., Davis, M.M., Rotter, J.S. et al. Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey. Support Care Cancer 27, 4779–4786 (2019). https://doi.org/10.1007/s00520-019-04742-z

Download citation

Keywords

  • Cancer survivorship
  • Financial toxicity
  • Rural health
  • Health disparities
  • Survey research